Literature DB >> 226834

Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.

J M Falko, G Schonfeld, J L Witztum, J Kolar, S W Weidman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 226834     DOI： 10.1016/0026-0495(79)90158-6

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  2 in total

1.  Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

Authors:  R J Havel; Y Chao; E E Windler; L Kotite; L S Guo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

2.  Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.

Authors:  S C Rall; K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.